Table 2 Prevalence of parasitaemia and description of parasite density, Magaria, Niger, 2016
From: Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
|
High season survey 1 October 2016 (N = 588) |
Low season survey 1 December 2016 (N = 634) |
High season survey 2 September 2017 (N = 818) |
Low season survey 2 February 2018 (N = 643) | |||||
|---|---|---|---|---|---|---|---|---|
| Gender, % (95% CI) | ||||||||
| Male | 42.5 | 36.7–48.5 | 41.2 | 36.1–46.4 | 47.4 | 42.5–52.4 | 36.3 | 31.4–41.6 |
| Female | 43.9 | 38.0–50.0 | 39.4 | 33.8–45.2 | 45.3 | 40.7–50.0 | 31.9 | 27.0–37.3 |
| Age, % (95% CI) | ||||||||
| 3–59 months | 51.9* | 45.1–58.6 | 48.1* | 41.4–54.9 | 50.7* | 44.8–56.6 | 39.6* | 33.2–46.4 |
| 5–9 years | 66.2 | 57.5–73.9 | 64.1 | 56.1–71.3 | 73.2 | 66.2–79.2 | 56.3 | 48.8–63.6 |
| ≥ 10 years | 23.6 | 18.6–29.4 | 21.0 | 16.6–26.2 | 29.9 | 25.4–34.8 | 14.8 | 10.9–19.7 |
| Type of SMC in the area, % (95%CI) | ||||||||
| Directly-observed first dose | 40.1 | 35.0–45.4 | 42.7 | 36.8–48.8 | 46.3 | 42.9–49.8 | 34.2 | 30.7–37.9 |
| Non-directly-observed first dose | 47.1 | 40.3–54.1 | 38.3 | 33.4–43.5 | – | – | – | – |
| Median parasitaemia (parasites/μl), IQR | ||||||||
| 3–59 months | 6066†§ | 1281–26,065 | 1320† | 489–4272 | 3932†§ | 459–24,312 | 797† | 227–1708 |
| 5–9 years | 1516§ | 530–5705 | 576 | 220–1495 | 1734§ | 495–7380 | 651 | 143–1517 |
| ≥ 10 years | 189§ | 126–629 | 103 | 63–159 | 168§ | 63–676 | 67 | 40–173 |